June 19, 2007 NASD OTC-BB: MRDAF

Meridian Signs Medical Endorsement Contract With Dr. Lionel Bissoon, a Prominent Celebrity Weight-Loss Doctor in the USA

Meridian Co., Ltd. ("Meridian" or the "Company") (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of integrative medical equipment, is thrilled to have Dr. Lionel Bissoon, a prominent celebrity weight-loss doctor, contract with the company to become the exclusive medical endorser for the LAPEX 2000 LipoLaser . This innovative new medical device is currently pending an FDA 510(k) clearance in the United States.

Dr. Bissoon is the leading authority in the U.S.A. on Mesotherapy (medical specialty focusing on promoting weight loss and eliminating cellulite) with practices in New York and Palm Beach. Dr. Bissoon is the best selling author of The Cellulite Cure and has been featured in numerous print and broadcast stories including appearances on ABC's "20/20", The Rachael Ray Show, CBS's "48 Hours", Vogue, People, and the New York Times.

Dr. Bissoon will work with Meridian regarding potential speaking or representation engagements at trade shows or medical conferences where he will discuss product information pertaining to the LAPEX 2000 LipoLaser. Dr. Bissoon is very excited about this new technology and commented, "The LAPEX 2000 LipoLaser holds the potential to revolutionize the aesthetic market for the reduction of cellulite and will offer clients a fantastic new non-invasive alternative to help them meet their goals."

More About: LAPEX 2000 LipoLaser

The LAPEX 2000 LipoLaser was designed to target the medical and aesthetic market, specifically to address body shaping/contouring, spot fat reduction, and reduction in the appearance of cellulite. The LAPEX 2000 LipoLaser's non-invasive treatment is considered one of the most innovative methods to treat those stubborn areas of fat that do not respond to diet and exercise. The demand for this type of treatment is expected to grow rapidly, not only in the plastic surgery profession but in any clinical setting such as medi-spas and wellness centers that treat localized body fat deposits which may not have responded to diet and exercise.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 18 worldwide patents on its technology, and has received FDA approval and Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 1500 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan and Europe, and continues to successfully market its superior product line to a growing number of clients worldwide.

On Behalf of the Board of Directors,

Hyeon Seong Myeong, President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Contacts:
Meridian Co., Ltd.
Peter Holeczek
Corporate Communications
1-866-736-3306
Website: https://MeridianMedical.ca